Essential Amino Acid Supplementation for Adult Spinal Deformity
This study is looking at whether taking an Essential Amino Acid Supplement by Amino Co can help adults with spinal deformity recover better after corrective surgery. Researchers want to see if this supplement, given for two weeks before surgery and three months after, can improve how your body builds and repairs muscle compared to a placebo (an inactive substance). You might be able to join if you are between 40 and 65 years old, have adult spinal deformity, are scheduled for surgery at UAMS, live near Little Rock, and will attend physical therapy there. The main goal is to measure muscle protein synthesis (how your body makes new muscle) 24 hours after surgery. The current recruitment status is unclear.
- Study design
- This is a randomized, double-blind, placebo-controlled study, meaning participants will be randomly assigned to receive either the supplement or a placebo, and neither you nor the researchers will know which you are receiving. The study plans to enroll 20 participants.
- What's involved
- You would take the Essential Amino Acid Supplement by Amino Co (or placebo) twice a day for two weeks before surgery and then for 12 weeks after surgery.
- Compensation
- Not stated in the trial record.
- Follow-up
- Muscle protein synthesis will be measured at 24 hours after surgery, and supplementation continues for 12 weeks post-surgery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Essential Amino Acid Supplementation in Adult Spinal Deformity Patients
At a glance
Conditions
NCT07341399
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University of Arkansas for Medical Sciences
Little Rock, Arkansasno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Shiloah Kviatkovsky · PRINCIPAL_INVESTIGATOR · UAMS
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Muscle Protein Synthesis24 hours
Mixed muscle protein synthesis expressed as the fractional synthetic rate.